View Entire Collection
By Clinical Topic
Diabetes – Summer 2012
Future of Nursing Initiative
Heart Failure - Fall 2011
Influenza - Winter 2011
Nursing Ethics - Fall 2011
Trauma - Fall 2010
Traumatic Brain Injury - Fall 2010
Fluids & Electrolytes
WEDNESDAY, July 14 (HealthDay News) -- Meningococcal polysaccharide vaccine (MPV4) does not appear to be associated with post-vaccination Henoch-Schönlein purpura (HSP) in 16- to 20-year-olds, according to research published online July 12 in Pediatrics.
Michael J. Goodman, Ph.D., of the University of Utah College of Pharmacy in Salt Lake City, and colleagues used data from the Vaccine Safety Datalink (VSD) to determine the 42-day post-vaccination incidence rate of HSP in the VSD population 16 to 20 years of age. The study was undertaken to determine whether periodic case reports of HSP after MPV4 vaccination were indications of an increased risk associated with the vaccine.
The researchers found the background incidence rate of HSP in the non-immunized population to be 4.2 per 100,000 person-years. After 49,027 doses of vaccine were administered, there were zero cases of HSP identified within 42 days. The authors concluded that these data provided strong evidence that HSP was not associated with receipt of MPV4 in the 16- to 20-year age group.
"These data strongly suggest that the MPV4 vaccine should be used, because no cases of HSP were found in the 42-day window after MPV4. For evaluating the risk of rare serious adverse events that may occur associated with a vaccine, large post-marketing studies are needed, which are especially important when the disease being prevented is rare. These data provide the strongest evidence so far that HSP is likely not associated with MPV4 in the 16- to 20-year age group," the authors write.
The VSD Study was funded through a subcontract with America's Health Insurance Plans.
Full Text (subscription or payment may be required)
Find in-depth content on major issues provided by leading companies in partnership with NursingCenter.com
BD Safety Beyond Needlestick Prevention Learning Center
Sponsored by BD Medical
Sign up for our free enewsletters to stay up-to-date in your area of practice - or take a look at an archive of prior issues
Join our CESaver program to earn up to 100 contact hours for only $34.95
Explore a world of online resources
Back to Top